This was further supported by in vitro experiments where RVL also inhibited IL-18 secretion, VCAM-1 expression and melanoma cell adhesion to tumor-activated HSE cells, three interrelated events regulating the microvascular arrest of circulating melanoma cells in the liver [2]. Here, IL18 is linked to melanoma.